You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

List of Excipients in API propofol


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing propofol

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Fresenius Kabi USA LLC DIPRIVAN propofol 63323-269 EDETATE DISODIUM ANHYDROUS
Fresenius Kabi USA LLC DIPRIVAN propofol 63323-269 EGG PHOSPHOLIPIDS
Fresenius Kabi USA LLC DIPRIVAN propofol 63323-269 GLYCERIN
Fresenius Kabi USA LLC DIPRIVAN propofol 63323-269 SODIUM HYDROXIDE
Fresenius Kabi USA LLC DIPRIVAN propofol 63323-269 SOYBEAN OIL
Fresenius Kabi USA LLC DIPRIVAN propofol 65219-800 EDETATE DISODIUM ANHYDROUS
Fresenius Kabi USA LLC DIPRIVAN propofol 65219-800 EGG PHOSPHOLIPIDS
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Subscribe

Excipients in ANDA-approved (generic) drugs containing propofol

Company Ingredient NDC Excipient
Pfizer Laboratories Div Pfizer Inc propofol 0069-0209 EDETATE DISODIUM
Pfizer Laboratories Div Pfizer Inc propofol 0069-0209 EGG PHOSPHOLIPIDS
Pfizer Laboratories Div Pfizer Inc propofol 0069-0209 GLYCERIN
Pfizer Laboratories Div Pfizer Inc propofol 0069-0209 SODIUM HYDROXIDE
Pfizer Laboratories Div Pfizer Inc propofol 0069-0209 SOYBEAN OIL
Pfizer Laboratories Div Pfizer Inc propofol 0069-0209 WATER
Henry Schein Inc propofol 0404-9943 EGG PHOSPHOLIPIDS
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Subscribe

Detailed excipient profiles for propofol

Excipient focus: BENZYL ALCOHOL

Excipient focus: EDETATE DISODIUM

Excipient focus: EDETATE DISODIUM ANHYDROUS

Excipient focus: EGG PHOSPHOLIPIDS

Excipient focus: GLYCERIN

Excipient focus: SODIUM BENZOATE

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SODIUM METABISULFITE

Excipient focus: SOYBEAN OIL

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group